Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-29 Sale | 2024-10-31 5:14 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 274 | $66.6 | $18,248 | 49,471 (Direct) | View |
2024-10-29 Sale | 2024-10-31 5:13 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,154 | $66.6 | $143,456 | 128,670 (Direct) | View |
2024-09-16 Sale | 2024-09-18 4:28 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 10,501 | $37.59 | $394,733 | 291,206 (Direct) | View |
2024-09-16 Sale | 2024-09-18 4:26 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 2,635 | $37.59 | $99,050 | 116,441 (Direct) | View |
2024-09-09 Sale | 2024-09-11 8:14 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 895 | $33.33 | $29,830 | 62,069 (Direct) | View |
2024-09-09 Sale | 2024-09-11 8:10 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,639 | $33.33 | $121,288 | 154,376 (Direct) | View |
2024-09-03 Sale | 2024-09-04 8:10 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 262 | $31.71 | $8,308 | 44,082 (Direct) | View |
2024-08-15 Sale | 2024-08-19 5:23 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 139,824 | $34.02 | $4,756,875 | 2,646,972 (Direct) | View |
2024-08-12 Sale | 2024-08-14 4:50 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 84,774 | $34.19 | $2,898,314 | 2,786,796 (Direct) | View |
2024-08-06 Sale | 2024-08-08 5:39 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 112,994 | $31.54 | $3,563,807 | 2,871,570 (Direct) | View |
2024-07-31 Sale | 2024-08-02 4:21 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 88,839 | $33.5 | $2,976,346 | 2,984,564 (Direct) | View |
2024-07-29 Sale | 2024-07-31 5:03 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 50,000 | $33.86 | $1,692,890 | 3,073,403 (Direct) | View |
2024-07-29 Sale | 2024-07-31 4:40 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,154 | $33.54 | $72,245 | 119,668 (Direct) | View |
2024-07-29 Sale | 2024-07-31 4:39 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 274 | $33.54 | $9,190 | 43,161 (Direct) | View |
2024-07-24 Sale | 2024-07-26 7:49 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 135,000 | $33.78 | $4,560,363 | 3,123,403 (Direct) | View |
2024-07-19 Sale | 2024-07-23 5:16 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 150,000 | $32.98 | $4,946,935 | 3,258,403 (Direct) | View |
2024-07-17 Sale | 2024-07-19 6:46 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 25,000 | $32.93 | $823,188 | 3,408,403 (Direct) | View |
2024-07-05 Sale | 2024-07-09 4:07 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 36,118 | $28.24 | $1,020,016 | 3,433,403 (Direct) | View |
2024-07-01 Sale | 2024-07-03 4:56 pm | GeneDx Holdings Corp. | WGS | OPKO HEALTH INC. 10% Owner | 89,082 | $27.58 | $2,457,286 | 3,469,521 (Direct) | View |
2024-06-17 Sale | 2024-06-18 5:18 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 2,646 | $28.31 | $74,908 | 116,575 (Direct) | View |
2024-06-17 Sale | 2024-06-18 5:17 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 7,683 | $28.31 | $217,506 | 297,080 (Direct) | View |
2024-06-10 Sale | 2024-06-11 4:14 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 895 | $24.92 | $22,303 | 57,479 (Direct) | View |
2024-06-10 Sale | 2024-06-11 4:13 pm | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 2,652 | $24.92 | $66,088 | 145,228 (Direct) | View |
2024-06-03 Purchase | 2024-06-05 8:45 pm | GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner | 130,000 | $21.21 | $2,757,117 | 3,862,697 (Indirect Direct) | View |
2024-06-03 Sale | 2024-06-04 4:20 pm | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 262 | $20.55 | $5,384 | 37,747 (Direct) | View |
2024-05-29 Purchase | 2024-05-31 5:37 pm | GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Eli Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Partners FO1-MSV LP Director 10% Owner | 40,000 | $21.07 | $842,604 | 3,732,697 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-29 Exercise | 2024-10-31 5:14 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 753 | $0 | 49,471 (Direct) | View |
2024-10-29 Exercise | 2024-10-31 5:13 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,874 | $0 | 128,670 (Direct) | View |
2024-10-15 Exercise | 2024-10-17 5:47 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Ryan Jason Director | 130 | $0 | 73,744 (Direct) | View |
2024-10-15 Exercise | 2024-10-17 5:41 pm | N/A N/A | GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director | 130 | $0 | 7,983 (Direct) | View |
2024-09-16 Exercise | 2024-09-18 4:28 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 291,206 (Direct) | View |
2024-09-16 Exercise | 2024-09-18 4:26 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 7,197 | $0 | 116,441 (Direct) | View |
2024-09-09 Exercise | 2024-09-11 8:14 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 2,462 | $0 | 62,069 (Direct) | View |
2024-09-09 Exercise | 2024-09-11 8:10 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 154,376 (Direct) | View |
2024-09-01 Exercise | 2024-09-04 8:10 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 717 | $0 | 44,082 (Direct) | View |
2024-08-01 Other | 2024-08-05 5:32 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Casdin Capital LLC Casdin Partners Master Fund L.P. Casdin Partners GP LLC Casdin Eli Director 10% Owner | 413,655 | $32.25 | 4,276,352 (Direct) | View |
2024-07-29 Exercise | 2024-07-31 4:40 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 3,874 | $0 | 119,668 (Direct) | View |
2024-07-29 Exercise | 2024-07-31 4:39 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 753 | $0 | 43,161 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:19 pm | N/A N/A | GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director | 12,924 | $0 | 12,924 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:18 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Leproust Emily M. Director | 12,924 | $0 | 12,924 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:16 pm | N/A N/A | GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director | 12,924 | $0 | 12,924 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:15 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Ryan Jason Director | 12,924 | $0 | 12,924 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:14 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner | 12,924 | $0 | 12,924 (Direct) | View |
2024-06-26 Option Award | 2024-06-27 4:13 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Meister Keith A. Director 10% Owner | 12,924 | $0 | 12,924 (Direct) | View |
2024-06-20 Exercise | 2024-06-24 7:04 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Casdin Eli Director 10% Owner | 5,828 | $0 | 3,867,148 (Direct) | View |
2024-06-20 Exercise | 2024-06-24 5:42 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Leproust Emily M. Director | 5,828 | $0 | 8,352 (Direct) | View |
2024-06-20 Exercise | 2024-06-24 5:41 pm | N/A N/A | GeneDx Holdings Corp. | WGS | PFENNIGER RICHARD C JR Director | 5,828 | $0 | 27,664 (Direct) | View |
2024-06-20 Exercise | 2024-06-24 5:40 pm | N/A N/A | GeneDx Holdings Corp. | WGS | RUCH JOSHUA Director | 5,828 | $0 | 202,117 (Direct) | View |
2024-06-20 Exercise | 2024-06-24 5:39 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Meister Keith A. Director 10% Owner | 5,828 | $0 | 3,647,868 (Direct) | View |
2024-06-16 Exercise | 2024-06-18 5:18 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 7,197 | $0 | 116,575 (Direct) | View |
2024-06-16 Exercise | 2024-06-18 5:17 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 18,750 | $0 | 297,080 (Direct) | View |
2024-06-09 Exercise | 2024-06-11 4:14 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 2,462 | $0 | 57,479 (Direct) | View |
2024-06-09 Exercise | 2024-06-11 4:13 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Stueland Katherine Chief Executive Officer | 6,546 | $0 | 145,228 (Direct) | View |
2024-06-01 Exercise | 2024-06-04 4:20 pm | N/A N/A | GeneDx Holdings Corp. | WGS | Feeley Kevin CHIEF FINANCIAL OFFICER | 717 | $0 | 37,747 (Direct) | View |